Showing results (31-40 of 296) with videos related to
Sort By:
Pageof 30
Biomaterials|September 27, 2005
The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matricesChang Yao, Martin Roderfeld, Timo Rath, et al.Expert Opinion on Drug Metabolism & Toxicology|September 28, 2014
Effect of drug transporter pharmacogenetics on cholestasisChristoph G Dietrich, Andreas GeierOncology Letters|August 7, 2012
Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migrationTimo Rath, Julia Stöckle, Martin Roderfeld, et al.Analytical Chemistry|April 9, 2024
Hepatic Topology of Glycosphingolipids in Schistosoma mansoni-Infected HamstersDavid Luh, Sven Heiles, Martin Roderfeld, et al.Scandinavian Journal of Gastroenterology|June 24, 2010
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitisTimo Rath, Martin Roderfeld, Jörg Michael Halwe, et al.Zeitschrift Fur Gastroenterologie|January 9, 2023
Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-RegistryAndreas Geier, Monika Rau, Anita Pathil-Warth, et al.Medizinische Klinik (Munich, Germany : 1983)|January 13, 2004
[Regulation of hepatobiliary transporters in cholestatic liver disease]Andreas Geier, Carsten Gartung, Siegfried MaternDeutsches Arzteblatt International|July 15, 2014
Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatmentJohannes Weiß, Monika Rau, Andreas GeierViruses|January 25, 2013
Host genetic variants in the pathogenesis of hepatitis CMonika Rau, Katharina Baur, Andreas GeierNature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael TraunerPageof 30